---
schema_version: "secwatch.filing_event.v1"
accession: "0000320017-24-000034"
form_type: "8-K"
ticker: "LSTA"
cik: "0000320017"
company_name: "LISATA THERAPEUTICS, INC."
filed_at: "2024-06-27T23:59:59+00:00"
generated_at: "2026-06-01T01:15:21.674905+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Lisata shareholders approve all six proposals at 2024 annual meeting

## Summary
- Re-elected Class II directors Brown, Henson, and Mazzo; votes ranged from 3.15M to 3.26M for.
- Approved 2018 Equity Plan amendment adding 600k shares and a 3-year evergreen clause (5% or board-set).
- Approved ESPP increase from 68,333 to 113,333 shares; 3.06M for, 131k against.
- Ratified Grant Thornton as auditor for FY2024; 3.71M for, 401k against, no broker non-votes.
- Non-binding advisory vote on executive compensation passed with 3.09M for, 417k against.

## SEC filing metadata
- accession: 0000320017-24-000034
- form_type: 8-K
- ticker: LSTA
- cik: 0000320017
- company_name: LISATA THERAPEUTICS, INC.
- filed_at: 2024-06-27T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/320017/000032001724000034/0000320017-24-000034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/320017/000032001724000034/clbs-20240627.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000320017-24-000034
- JSON: https://secwatch.observer/filing/0000320017-24-000034.json
- Plain text: https://secwatch.observer/filing/0000320017-24-000034.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.